BRPI0415390A - compostos de pirazinona substituìda para o tratamento da inflamação - Google Patents

compostos de pirazinona substituìda para o tratamento da inflamação

Info

Publication number
BRPI0415390A
BRPI0415390A BRPI0415390-1A BRPI0415390A BRPI0415390A BR PI0415390 A BRPI0415390 A BR PI0415390A BR PI0415390 A BRPI0415390 A BR PI0415390A BR PI0415390 A BRPI0415390 A BR PI0415390A
Authority
BR
Brazil
Prior art keywords
inflammation
treatment
sup
substituted pyrazinone
pyrazinone compounds
Prior art date
Application number
BRPI0415390-1A
Other languages
English (en)
Inventor
Mark L Boys
Michael Clare
Mark J Mitton-Fry
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BRPI0415390A publication Critical patent/BRPI0415390A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

"COMPOSTOS DE PIRAZINONA SUBSTITUìDA PARA O TRATAMENTO DA INFLAMAçãO". São descritos inibidores de quinase com a Fórmula (I): em que X, R¬ a¬, R¬ b¬, R¬ c¬, e R¬ d¬ são tal como definidos no documento presente.
BRPI0415390-1A 2003-10-14 2004-10-04 compostos de pirazinona substituìda para o tratamento da inflamação BRPI0415390A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51087003P 2003-10-14 2003-10-14
PCT/IB2004/003238 WO2005035527A1 (en) 2003-10-14 2004-10-04 Substituted pyrazinone compounds for the treatment of inflammation

Publications (1)

Publication Number Publication Date
BRPI0415390A true BRPI0415390A (pt) 2006-12-12

Family

ID=34435133

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415390-1A BRPI0415390A (pt) 2003-10-14 2004-10-04 compostos de pirazinona substituìda para o tratamento da inflamação

Country Status (10)

Country Link
US (1) US20070225291A1 (pt)
EP (1) EP1678164B1 (pt)
JP (1) JP3962425B2 (pt)
AT (1) ATE359283T1 (pt)
BR (1) BRPI0415390A (pt)
CA (1) CA2541667A1 (pt)
DE (1) DE602004005881T2 (pt)
ES (1) ES2284054T3 (pt)
MX (1) MXPA06003746A (pt)
WO (1) WO2005035527A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR050253A1 (es) 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
ATE479687T1 (de) 2004-10-15 2010-09-15 Takeda Pharmaceutical Kinaseinhibitoren
NZ563687A (en) 2005-06-30 2011-07-29 Smithkline Beecham Corp 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[2-(1-methylethyl)-2,3-dihydro-1H-isoindol-5-yl]-1H-indole-7-carboxamide for inhibiting IKK2 (aka IKKbeta)
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2007149448A2 (en) * 2006-06-21 2007-12-27 E. I. Du Pont De Nemours And Company Pyrazinones as cellular proliferation inhibitors
GEP20135728B (en) 2006-10-09 2013-01-25 Takeda Pharmaceuticals Co Kinase inhibitors
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
MY153258A (en) 2007-06-27 2015-01-29 Astrazeneca Ab Pyrazinone derivatives and their use inthe threatment of lung diseases
MX2010013478A (es) * 2008-07-02 2010-12-20 Hoffmann La Roche Nuevas fenilpirazinonas como inhibidores de cinasa.
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
EP2575799A4 (en) * 2010-05-19 2013-11-13 Beth Israel Hospital METHOD FOR THE TREATMENT OF INFLAMMABLE AUTOIMMUNE DISEASES
CN104718201A (zh) 2012-06-12 2015-06-17 艾伯维公司 吡啶酮和哒嗪酮衍生物
CA2909510C (en) * 2013-03-15 2024-04-02 Cancer Research Technology, Llc Methods and compositions for gamma-glutamyl cycle modulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260293A (en) * 1988-01-30 1993-11-09 Merck Sharp & Dohme Limited Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
JP2002193938A (ja) * 2000-12-01 2002-07-10 Bayer Ag ４−アリールピリジン誘導体
JP2005511608A (ja) * 2001-11-07 2005-04-28 エフ．ホフマン−ラ　ロシュ　アーゲー アミノピリミジン類及び−ピリジン類

Also Published As

Publication number Publication date
DE602004005881D1 (de) 2007-05-24
ES2284054T3 (es) 2007-11-01
EP1678164B1 (en) 2007-04-11
EP1678164A1 (en) 2006-07-12
US20070225291A1 (en) 2007-09-27
ATE359283T1 (de) 2007-05-15
MXPA06003746A (es) 2006-06-14
JP2007508366A (ja) 2007-04-05
WO2005035527A1 (en) 2005-04-21
JP3962425B2 (ja) 2007-08-22
DE602004005881T2 (de) 2008-01-17
CA2541667A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
UA91002C2 (ru) 7-фенилалкилзамещенные 2-хинолиноны и 2-хиноксалиноны как ингибиторы поле(адф-рибоза)полимеразы
YU5503A (sh) Nesteroidni supresori zapaljenja
GB0100889D0 (en) Compounds
RS51445B (en) PYROLIDINDION SUBSTITUTED BY PIPERIDINE-PTHALAZONE AS PDE4 INHIBITORS
TW200610531A (en) Phthalazine derivatives as PARP inhibitors
CY1110064T1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
NO20082266L (no) Nye 1-azabicykloalkylderivater for behandling av psykotiske og neurodegenerative forstyrrelser
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
EA200801199A1 (ru) Ингибиторы киназы
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
BRPI0415390A (pt) compostos de pirazinona substituìda para o tratamento da inflamação
EA200801200A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛИЗОХИНОЛИНМОЧЕВИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ p38 КИНАЗЫ
MXPA05010875A (es) Derivados de piperazina como inhibidores de renina.
NO20044526L (no) Hemisterlinderivater og anvendelser derav
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
SE0103710D0 (sv) Compounds
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
AP2002002466A0 (en) 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS.
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
PL1845780T3 (pl) Zastosowanie pochodnych metylofenidatu
GB0308201D0 (en) Novel compounds
UA96745C2 (en) PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.